**Core Concept**
Aminophylline is a medication used in the treatment of **bronchial asthma**, which is a chronic inflammatory disease of the airways. The underlying pharmacological principle being tested involves the relaxation of **bronchial smooth muscles**. This is crucial for relieving **bronchospasm** associated with asthma.

**Why the Correct Answer is Right**
Aminophylline works by inhibiting **phosphodiesterase**, an enzyme that breaks down **cyclic adenosine monophosphate (cAMP)** and **cyclic guanosine monophosphate (cGMP)**. By inhibiting this enzyme, aminophylline increases the levels of cAMP and cGMP, leading to relaxation of bronchial smooth muscles. This action is mediated through the activation of **protein kinase A**, which in turn inhibits the contraction of smooth muscle cells.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it does not accurately describe the primary mechanism of action of aminophylline.
**Option B:** Incorrect as it is unrelated to the mechanism by which aminophylline exerts its therapeutic effect in bronchial asthma.
**Option C:** Incorrect because, although aminophylline does have some effects on the cardiovascular system, this is not its primary mechanism in treating asthma.
**Option D:** Incorrect as it is not the correct description of how aminophylline works in the context of bronchial asthma.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that aminophylline, being a **methylxanthine derivative**, not only relaxes bronchial smooth muscles but also has **anti-inflammatory properties**, although its use is limited by a narrow therapeutic index and potential for **side effects**.

**Correct Answer:** Correct Answer: D. Inhibition of phosphodiesterase.